BLT 0.00% 2.6¢ benitec biopharma limited

special report - blt, page-12

  1. 1,411 Posts.
    lightbulb Created with Sketch. 43
    KSS is nothing!

    The more this trial proves that ddRNAi (TT-034) as a platform technology is a major
    threat to large pharma companies the more manipulation I expect from those campanies online and in court.

    Early days Mud.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.